US STOCK
EW Stock Analysis
US stocks · market data · technical indicators
Edwards Lifesciences Corp
EWUS stocksQuote delayed 15 min
10/26 下午04:19 updated
$89.07
-1.02-1.13%
Open
$90.11
High
$91.05
Low
$88.97
Volume
310.18萬
EW price history
+2.58%Open
86.83
Latest
89.07
High
90.09
Low
84.24
Average
86.82
Advertisement
Financial snapshot
EW - Edwards Lifesciences Corporation
EPS
1.71USD
Forward EPS
3.37USD
P/E
52.09x
Forward P/E
26.40x
P/B
4.84x
ROE
9.18%
ROA
8.37%
Operating margin
29.84%
Profit margin
15.43%
Revenue growth
13.60%
Earnings growth
-25.40%
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | — | $1.65B | $1.57B | $1.55B | $1.53B | $1.41B |
| Gross profit | — | $1.29B | $1.23B | $1.21B | $1.19B | $1.11B |
| Operating income | — | $514.70M | $370.30M | $425.10M | $430.90M | $409.90M |
| Net income | — | $380.70M | $91.20M | $291.10M | $333.20M | $358.00M |
| Basic EPS | 0.42 | 0.66 | 0.16 | 0.50 | 0.57 | — |
| Diluted EPS | 0.42 | 0.66 | 0.16 | 0.50 | 0.56 | — |
Estimates vs actuals
Next earnings
2026-11-04
EPS estimate
0.74
Revenue estimate
$1.68B
Last surprise
+5.25%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-04 | 0.74 | Not reported | — |
| 2026-07-23 | 0.74 | 0.78 | +5.25% |
| 2026-04-23 | 0.73 | 0.78 | +7.33% |
| 2026-02-10 | 0.62 | 0.58 | -6.27% |
| 2025-10-30 | 0.59 | 0.67 | +12.63% |
| 2025-07-24 | 0.62 | 0.67 | +7.64% |
| 2025-04-23 | 0.60 | 0.64 | +7.46% |
| 2025-02-11 | 0.55 | 0.59 | +6.39% |
| 2024-10-24 | 0.59 | 0.67 | +13.97% |
| 2024-07-24 | 0.69 | 0.70 | +0.88% |
| 2024-04-25 | 0.64 | 0.66 | +2.79% |
| 2024-02-06 | 0.64 | 0.64 | +0.16% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $6B | 0.09% |
| BlackRock Inc. | 2024-06-30 | $4.7B | 0.11% |
| STATE STREET CORP | 2026-06-30 | $2.4B | 0.07% |
| CITADEL ADVISORS LLC | 2026-06-30 | $361.7M | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $137.7M | 0.10% |
| Bridgewater Associates, LP | 2026-06-30 | $24.9M | 0.10% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $1.9M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$101.39
Target range
$84.00 – $110.00
Implied upside
13.83%
Strong buy
5
Buy
18
Hold
7
Sell
0
Strong sell
0
Advertisement